Antonetti Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Antonetti Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$422K	Sell	5,784 -158	-3%	-$12.6K	0.66%	24
2023 Q2	$494K	Hold	5,942	–	–	0.71%	23
2023 Q1	$453K	Buy	5,942 +84	+1%	+$6.97K	0.66%	21
2022 Q4	$486K	Sell	5,858 -240	-4%	-$19.4K	0.67%	23
2022 Q3	$484K	Sell	6,098 -12	-0.2%	-$1.01K	0.56%	25
2022 Q2	$454K	Buy	6,110 +131	+2%	+$9.83K	0.48%	31
2022 Q1	$537K	Buy	5,979 +214	+4%	+$19.8K	0.5%	30
2021 Q4	$645K	Buy	+5,765	New	+$695K	0.51%	34

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Antonetti Capital Management's XBI Position: Q3 2023 in Review

Antonetti Capital Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.7% in Q3 2023, selling an estimated $12.6K and leaving 5,784 shares worth $422K. The position accounts for 0.66% of the portfolio, ranked #24.

Antonetti Capital Management first reported a position in XBI in Q4 2021 and has held it in 8 quarters since. The position peaked at $645K in Q4 2021. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Antonetti Capital Management held 5,784 shares of State Street SPDR S&P Biotech ETF worth $422K as of Q3 2023.
Antonetti Capital Management sold 158 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $12.6K.
State Street SPDR S&P Biotech ETF made up 0.66% of Antonetti Capital Management's portfolio in Q3 2023, its #24 holding.
Antonetti Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 8 quarters since.
Antonetti Capital Management's State Street SPDR S&P Biotech ETF position peaked at $645K in Q4 2021.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.